FDA.reportPublic FDA data

AMPRENAVIR Pharmacologic Class Indexing

Class set ID
59748cde-a60b-49a3-9a22-8b897beb5ddc
Version
4
Effective date
20181113
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use FOSAMPRENAVIR CALCIUM TABLETS safely and effectively. See full prescribing information for FOSAMPRENAVIR CALCIUM TABLETS. FOSAMPRENAVIR CALCIUM tablets, for oral use Initial U.S. Approval: 2003Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc.2025042510
These highlights do not include all the information needed to use FOSAMPRENAVIR CALCIUM TABLETS safely and effectively. See full prescribing information for FOSAMPRENAVIR CALCIUM TABLETS. FOSAMPRENAVIR CALCIUM tablets, for oral use Initial U.S. Approval: 2003Mylan Pharmaceuticals Inc.202309156
These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA. LEXIVA (fosamprenavir calcium) Tablets, for oral use LEXIVA (fosamprenavir calcium) Oral Suspension Initial U.S. Approval: 2003State of Florida DOH Central Pharmacy201501101
These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA. LEXIVA (fosamprenavir calcium) Tablets and Oral Suspension Initial U.S. Approval: 2003State of Florida DOH Central Pharmacy201004141